NCT05237492 is a Phase 4 clinical trial of Tramadol in Drug Toxicity, sponsored by Medical University of Graz.

Who is sponsoring NCT05237492?

NCT05237492 is sponsored by Medical University of Graz.

What drugs are being tested in NCT05237492?

Interventions in NCT05237492: Tramadol.

What condition does NCT05237492 study?

NCT05237492 studies Drug Toxicity, Platelet Dysfunction, Clotting Disorder.

Is NCT05237492 still recruiting?

NCT05237492 is currently completed. Last updated 18 January 2024.

Last reviewed 2024-01-18 · How we verify

NCT05237492

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Influence of Tramadol on Platelet Function

Completed Phase 4 Last updated 18 January 2024

What this trial tests

Phase 4 trial testing Tramadol in Drug Toxicity in 33 participants. Completed in 15 July 2023.

Timeline

26 January 2022

Primary endpoint
15 July 2023

15 July 2023

Quick facts

Lead sponsor	Medical University of Graz
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	33
Start date	26 January 2022
Primary completion	15 July 2023
Estimated completion	15 July 2023
Sites	1 location across Austria

Drugs / interventions tested

Tramadol (tramadol) — full drug profile →

Conditions studied

Drug Toxicity — all drugs for Drug Toxicity →
Platelet Dysfunction — all drugs for Platelet Dysfunction →
Clotting Disorder — all drugs for Clotting Disorder →

Sponsor

Medical University of Graz

Who can join

18 and older, any sex, with Drug Toxicity or Platelet Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this ex-vivo study is to quantify the effect of tramadol on platelet aggregation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Tramadol

Trials testing the same drug.

NCT07064993 — Effects of Intraarticular Tramadol and Tramadol-Dexamethasone on Postoperative Pain After Knee Arthroscopy · Phase 4 · not yet recruiting
NCT07346872 — EXORA Block vs Epidural Analgesia in Gynecological Surgery · NA · active not recruiting
NCT07066111 — The Effect of Bupivacaine Liposome Preemptive Analgesia on Postoperative Pain and Delirium in Elderly Patients Undergoin · Phase 4 · not yet recruiting
NCT07332572 — COMPARISON OF INTRAVENOUS DEXMEDETOMEDINE AND TRAMADOL FOR POST OPERATIVE SHIVERING AFTER SPINAL ANESTHESIA FOR CAESAREA · Phase 4 · completed
NCT07110051 — Nalbuphine Versus Tramadol on Post Operative Analgesia in Abdominal Surgery on Pediatric Cancer Patient · NA · recruiting

Other recruiting trials for Drug Toxicity

Currently open trials in the same condition.

NCT05512169 — Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia · recruiting
NCT04696081 — Atrial Fibrillation in Active Cancer Patients · recruiting
NCT04659343 — TDM for Optimized Outcome in Patients With mRCC. · recruiting
NCT04305145 — Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis · Phase 2 · active not recruiting

Other Medical University of Graz trials

Trials by the same sponsor.

NCT07498244 — Collagen Fingerprinting for Stratification of Pulmonary Hypertension (PH) Patients · recruiting
NCT07492823 — Clinical Applicability of Liquid Biopsy in Chondrosarcoma · not yet recruiting
NCT07297615 — 3D Liver Volumetry · NA · not yet recruiting
NCT07588282 — The Effect of Psychoeducational Diagnosis Communication on Perception of Illness, Satisfaction, and Behavioral Intention · NA · recruiting
NCT07376096 — Liquid Biopsy in Germ Cell Tumors · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05237492 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Graz
Last refreshed: 18 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05237492.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing